We take controlling stakes in proven manufacturers and work with management to expand capacity, improve operations, and build long-term value.
Zenrock Chemicals is a Mumbai-based strategic acquirer focused exclusively on India's specialty chemicals sector. We take majority positions in established manufacturers with demonstrated product-market fit, operational track records, and clear paths to scale.
Our model is straightforward: acquire control, strengthen operations, expand capacity, and exit to larger strategic or financial buyers. We deploy patient capital backed by institutional debt and equity, allowing us to move decisively on the right opportunities.
Founded in 2025, Zenrock operates as a platform builder rather than a passive investor. We work alongside existing management teams, providing capital, operational expertise, and market access to accelerate growth trajectories already in motion.
Sector Focus: Specialty Chemicals Only. India's chemicals sector is consolidating rapidly as smaller promoter-held businesses seek liquidity and professionalization. We focus on manufacturers of industrial intermediates and niche formulations where India has raw material access, cost advantages, and export potential. We avoid commodity chemicals and capital-intensive bulk production.
Stage & Structure: Control Acquisitions with Debt Leverage. We acquire more than 50% stakes via negotiated block deals, typically triggering SEBI open offers to consolidate control. Transactions are structured with a mix of institutional debt and equity, allowing us to compete on speed and certainty. We prefer family-owned businesses transitioning to professional ownership and carve-outs from larger groups.
Value Creation: Operational, Not Financial Engineering. Post-acquisition, we focus on capacity expansion, working capital optimization, margin improvement, and customer diversification. We don't flip companies — we build them. Our edge is operational rather than financial: we understand chemical manufacturing economics, regulatory landscapes, and export market dynamics.
Exit Philosophy: Strategic Sales & PE Buyouts. Exits are structured around strategic acquisitions by larger chemicals groups, secondary sales to growth-stage PE funds, or in select cases, public market listings. We design every investment with multiple exit pathways from day one.
Market Capitalization: ₹891 Crores (as of May 2026)
Indo Borax manufactures boron-based chemicals including boric acid, borax decahydrate, and lithium hydroxide monohydrate. Products serve pharmaceutical, glass, ceramics, fertilizer, and industrial applications across domestic and export markets.
The company operates manufacturing facilities at Pithampur, Madhya Pradesh, with recent capacity additions in value-added derivatives including Disodium Octaborate Tetrahydrate (DOT) and Boron Oxide. Indo Borax serves a diversified customer base spanning agrochemicals, specialty glass manufacturing, pharmaceutical intermediates, and industrial process chemicals.
Director
Sunil Malhotra is a seasoned serial entrepreneur with a track record of building, scaling, and strategically exiting multiple businesses across diverse sectors. Known for his ability to identify emerging market opportunities and shape them into high-growth ventures, he has consistently operated at the intersection of business creation and investment strategy.
In addition to his entrepreneurial pursuits, Sunil is an active investor across multiple private equity funds. He is a designated partner at She Capital LLP, a pioneering fund focused on supporting and scaling women-led businesses in India, championing both gender diversity and next-generation entrepreneurship.
Today, Sunil continues to work across venture development and private capital, shaping businesses with strategic foresight and a founder-first philosophy.
506, Tulsiani Chambers
Freepress Journal Marg, Nariman Point
Mumbai, Maharashtra 400021
India
CIN: U20110MH2025PTC445086
Incorporated: April 8, 2025
RoC: Mumbai